Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.

Li, Philip Kam-Tao

Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. [electronic resource] - American journal of kidney diseases : the official journal of the National Kidney Foundation May 2006 - 751-60 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1523-6838

10.1053/j.ajkd.2006.01.017 doi


Adult
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Double-Blind Method
Female
Glomerulonephritis, IGA--drug therapy
Hong Kong
Humans
Male
Tetrazoles--therapeutic use
Valine--analogs & derivatives
Valsartan